International Symposium on Cancer Immunotherapy: Featuring Today's Innovators, Tomorrow's Leaders

November 4, 2015
2 p.m. – 8:30 p.m.
The Sunset Room by Wolfgang Puck

 

Organizers

Organized in collaboration with the World Immunotherapy Council

Program Purpose

The Society for Immunotherapy of Cancer and the World Immunotherapy Council are dedicated to advancing cancer immunotherapy and, likewise, the future leaders of the field. This program provided the opportunity for young scientists and future leaders from throughout the world to interact, fulfilling the World Immunotherapy Council’s mission to facilitate rapid development and global dissemination of cancer immunotherapies through scientific exchange.

The young investigators, each chosen for exemplary work in the field of cancer immunotherapy, contributed insight and perspectives into present and future issues, challenges, and improvements as cancer immunotherapy is integrated into mainstream cancer treatment. This program and its participants highlighted worldwide initiatives in cancer immunotherapy and facilitated scientific exchange and networking between today’s and tomorrow’s leaders. Additionally, this forum provided a unique opportunity to showcase the world’s young, talented scientists and provide an opportunity for knowledge exchange and networking for these selected representatives.

Intended Audience

The target audience for this program consisted of individuals from academic institutions, industry and regulatory agencies, including clinicians, basic and translational researchers, graduate students, post-doctoral fellows, and allied health professionals who wished to learn more about the future of cancer immunotherapy research across the globe.

Educational Objectives

Upon completion of this meeting, participants are now able to:

• Recognize ongoing cancer immunotherapy research across the globe.
   
• Translate worldwide state-of-the-art cancer immunotherapy strategies into practice 1.
   
• Identify the unique challenges and future issues as cancer immunotherapy is integrated into mainstream cancer treatment modalities.

Participating World Immunotherapy Council Members

	Chinese Society of Clinical Oncology (CSCO)
Cancer Drug Development Forum (CDDF)	European Academy of Tumor Immunology (EATI)
Italian Network for Tumor Biotherapy	Japanese Association of Cancer Immunotherapy (JACI)
Middle Eastern and North African Interest Group	Scandinavian Network for Immunotherapy of Cancer
Società Campana di ImmunoTerapia Oncologica (SCITO)

The International Symposium on Cancer Immunotherapy: Featuring Today's Innovators, Tomorrow's Leaders was supported in part by grants from AstraZeneca, Inovio Pharmaceuticals, and MacroGenics, Inc..